The Multifaceted Future of Pharma – Chapter 1: The Big Picture
Paula Casalino, Vice President of Operations with IPS and ISPE FOYA Planning Committee Chair, has shared her thoughts on collaboration and innovation with the Medicine Maker in "The Multifaceted Future of Pharma – Chapter 1: The Big Picture."
Casalino answers the following question below, “Looking ahead to the next 5–10 years, what will be the key disruptors and/or what can be improved upon in the pharma industry?”
“In the next 10 years, I would like to see life-saving drugs delivered to the market faster and cheaper than ever before. While we have made many advancements globally towards achieving this goal, the two biggest opportunities that I believe will result in the greatest impact are in the areas of collaboration and innovation. This would start with greater collaboration across governments around the world, at all levels, and extend to life sciences organizations, their leaders, and across the entire supply chain – from raw material suppliers through equipment vendors, design partners, contractors, and distribution. This would also include a significant focus on technology and innovation. We will continue to see tremendous advancements in generative AI, smart factories, end-to-end visibility, and transparency. This is an extremely complex undertaking involving many different stakeholders, but I believe with greater collaboration and continuous innovation, we will drive better outcomes for delivering lifesaving drugs to market faster and more cost-effectively.
“To help achieve such lofty goals, industry organizations and nonprofits that provide a platform to share best practices in manufacturing help bring together leaders to enable collaboration between companies. Whether sharing insights and knowledge on the latest technologies or forming communities of practice to address common challenges in the industry, companies will need to learn from each other to implement new strategies effectively.”
Note: This article is behind a paywall. Viewers may sign up to view the full article.
About the Medicine Maker
Medicine Maker covers pressing topics, trends, and technologies covering the entire spectrum of drug development. The publication highlights industry success stories and insights from professionals who develop and manufacture small molecules, biologics, and advanced therapies.